Journal article

Decline in serum 25 hydroxyvitamin D levels in HIV-HBV-coinfected patients after long-term antiretroviral therapy

Anchalee Avihingsanon, Tanakorn Apornpong, Reshmie A Ramautarsing, Sasiwimol Ubolyam, Pisit Tangkijvanich, Jintanat Ananworanich, Joep MA Lange, Gail Matthews, Sharon R Lewin, Kiat Ruxrungtham

ANTIVIRAL THERAPY | INT MEDICAL PRESS LTD | Published : 2014

Abstract

BACKGROUND: Vitamin D insufficiency plays an important role in the development of fibrosis in chronic liver disease. METHODS: This was a cross-sectional study from Thailand. Liver fibrosis was assessed by transient elastography. Serum 25 hydroxyvitamin D (25[OH]D)14 kPa. Median (IQR) duration on TDF was 5 years (4-7). The median estimated glomerular filtration rate was 96.9 ml/min/1.73 m(2). The median (IQR) serum 25(OH)D levels prior to and following TDF were 24.8 ng/ml (21.3-30.6) and 22.8 ng/ml (18.0-27.7), respectively; P≤0.001). The proportion of patients with hypovitaminosis D significantly increased from 72.2% (95% CI 64.7, 78.6) prior to TDF to 84.2% (95% CI 77.7, 89.0) after taking ..

View full abstract

University of Melbourne Researchers

Grants

Awarded by National Research Council of Thailand (NRCT)


Awarded by Thailand Research Fund (TRF)


Awarded by Ratchadapisek Sompotch Endowment Fund (Faculty of Medicine, Chulalongkorn University)


Funding Acknowledgements

This study (clinical trial number NCT01138241) was funded by the National Research Council of Thailand (NRCT) under grant number Por Kor/2554-136 (5 September 2011), the Thailand Research Fund (TRF) under grant number RSA5380002, BRG5580005, the Ratchadapisek Sompotch Endowment Fund (Faculty of Medicine, Chulalongkorn University) under grant number RA33/53 (25 June 2010), Research Unit of Hepatitis and Liver Cancer, Chulalongkorn University, and the Aligning Care and Prevention of HIV/AIDS with Government Decentralization to Achieve Coverage and Impact (ACHIEVED Project; The Global fund Project, Thailand).